JG
EBS icon

Jain Global’s Emergent Biosolutions EBS Stock Holding History

Jain Global’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Sell
198,984
-743,707
-79% -$7.7M 0.01% 721
2025
Q4 		$11.7M Buy
942,691
+433,984
+85% +$4.65M 0.06% 305
2025
Q3 		$4.49M Buy
+508,707
New +$3.96M 0.02% 387
2025
Q2 		– Sell
-63,914
Closed -$311K – 1295
2025
Q1 		$311K Buy
63,914
+7,641
+14% +$63.2K ﹤0.01% 669
2024
Q4 		$538K Buy
+56,273
New +$516K 0.02% 430

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jain Global's EBS Position: Q1 2026 in Review

Jain Global reduced its Emergent Biosolutions (EBS) stake by 79% in Q1 2026, selling an estimated $7.7M and leaving 198,984 shares worth $1.65M. The position accounts for 0.01% of the portfolio, ranked #721.

Jain Global first reported a position in EBS in Q4 2024 and has held it in 5 quarters since. The position peaked at $11.7M in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Jain Global held 198,984 shares of Emergent Biosolutions worth $1.65M as of Q1 2026.
  • Jain Global sold 743,707 Emergent Biosolutions shares in Q1 2026, an estimated $7.7M.
  • Emergent Biosolutions made up 0.01% of Jain Global's portfolio in Q1 2026, its #721 holding.
  • Jain Global first reported a position in Emergent Biosolutions in Q4 2024 and has held it in 5 quarters since.
  • Jain Global's Emergent Biosolutions position peaked at $11.7M in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.